Fischer Medical Ventures Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

FISCHER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+5.9%1-day move

₹38.81

prior close

₹39.11

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.6+1.0+1.0+1.0+5.9+5.6+5.5+4.6+5.6+5.3-2.6-1.6-6.6+8.0

Up moveDown movePending

AI summary

Fischer Medical Ventures has informed the stock exchanges that its trading window will be closed for insiders from April 1, 2026, until 48 hours after the company announces its audited financial results for the financial year ending March 31, 2026. During this period, promoters, directors, designated persons, and their immediate relatives are prohibited from trading in the company's shares. This is a routine compliance action under SEBI's Insider Trading Regulations, typically observed ahead of a major financial results announcement. A separate intimation regarding the board meeting to approve the audited results will follow.

Likely market impact

This is a standard regulatory disclosure and does not directly affect the stock price. However, it signals that the audited FY26 results are imminent, which investors should watch for as it could influence near-term sentiment and trading activity once the window reopens.